Phase II
Discontinuation of LOTIS-9 Trial: Zynlonta in Unfit DLBCL Patients
SG Tylor
Source – ADC Therapeutics On July 20, 2023, ADC Therapeutics announced its decision to discontinue the Phase II LOTIS-9 clinical ...
Pfizer Unveils Promising GBS Maternal Vaccine in New England Journal of Medicine
SG Tylor
Source – Pfizer On July 19, Pfizer released promising data from a Phase II study of their GBS6 vaccine candidate, ...
First Wave BioPharma’s Pancreatic Enzyme Replacement Therapy Faces Hurdles, Stock Plummets
SG Tylor
Source – First Wave BioPharma First Wave BioPharma, formerly known as AzurRx BioPharma, has faced ongoing challenges in bringing a ...
